腫瘍学におけるAIM2炎症体およびピロプトーシスバイオマーカー
Rajiv Dahiya1, Abedalrahman Shqaidef2, Soumya V Menon3
1School of Pharmacy, Faculty of Medical Sciences, The University of the West Indies, St. Augustine, Trinidad and Tobago.
Clinica chimica acta; international journal of clinical chemistry
|February 21, 2026
まとめ
インフラマソームとピロプトーシスバイオマーカーは,がんに関する新しい洞察を提供します. このレビューは,これらの細胞死信号を腫瘍学診断および治療モニタリングで使用するための枠組みを詳細に説明しています.
科学分野:
- 腫瘍学 腫瘍学
- 免疫学 免疫学とは
- バイオマーカーの発見
背景:
- 炎症は癌の鍵ですが,炎症細胞の活性化と熱死は標準的な腫瘍学試験では十分に活用されていません.
- 炎症体調節による細胞死であるピロプトーシスは,サイトカインやガスダーミンの割れ分産物などの検出可能な信号を放出します.
- これらの信号は,新しいがん診断と治療モニタリングの可能性を秘めています.
研究 の 目的:
- 腫瘍学におけるAIM2関連炎症体/ピロプトーシスバイオマーカーのトランスレーション研究室の枠組みを提示する.
- 生物学的根拠,臨床用例,およびバイオマーカーの実装のための検証手順を概説する.
- 患者の分層化や治療モニタリングなどのアプリケーションのための候補測定値を分類する.
主な方法:
- インフラマソーム/ピロプトーシスバイオマーカーの体系的なレビューとその分析的検証.
- 免疫ヒスト化学と循環するバイオマーカーを含む臨床研究室で利用可能な測定法に焦点を当てます.
- 分析特性,免疫検査の干渉,治療用抗体効果についての議論.
主要な成果:
- 腫瘍内AIM2,循環するASC複合体,IL-1β/IL-18プロテオフォーム,cfDNAフラグメントミクス,ガスダーミンの割れ分産物を含むバイオマーカーの分類.
- 精密な測定と定義,校正,トレーサビリティ,性能の特徴付けに重点を置いています.
- 潜在的な免疫検査の干渉と治療的抗体効果の特定.
結論:
- 炎症体/ピロプトーシスバイオマーカーの用途に適した翻訳的枠組みが,腫瘍学のために提案されています.
- オートゴナル確認,干渉検査,臨床的に有意義な報告を優先することは,採用に不可欠です.
- この枠組みから派生した再現可能なバイオマーカーは,がん治療における臨床的意思決定を強化することができます.
関連する概念動画
The Intrinsic Apoptotic Pathway
8.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.8K
The Extrinsic Apoptotic Pathway
8.9K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.9K
PI3K/mTOR/AKT Signaling Pathway
5.8K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.8K
NF-κB-dependent Signaling Pathway
10.1K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
10.1K
Phagocytosis of Apoptotic Cells
5.3K
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized...
Normal cells contain receptors that prevent them from being recognized...
5.3K
The JAK-STAT Signaling Pathway
13.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.3K


